DOCRODiagnostic Oncology Clinical Research Organization (Seymour, CT)
References in periodicals archive ?
The co-marketing agreement with DOCRO provides ACSL customers with access to a full suite of validation and regulatory clinical trial services and resources.
For the past 10 years, DOCRO has a proven formula for success that has led to an unparalleled track record with the FDA, making DOCRO the clear choice for FDA pre-market approvals.
We are very excited to work with the highly experienced and enthusiastic team at DOCRO," said Cynthia French, Ph.
DOCRO is headquartered in Seymour, Connecticut, and has been servicing the IVD industry for more than 10 years.
With more than half of the IVD pre-market approvals during the past decade, DOCRO has demonstrated its expertise and real-world experience in the development, clinical validation and market-making introduction of many of the then innovative, but now standard, diagnostic tests in the field of oncology.
Lexon has retained DOCRO to configure the Ebaf Assay(TM) for the ELISA platform, a generally accepted immunological testing format used worldwide.
DOCRO assists members of these industries in the development, clinical validation, approval and sale of new products.
By improving the cost-effectiveness and decreasing the duration of these studies, DOCRO helps companies submit applications to the FDA faster.